GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $23,000 | -4.2% | 539 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $24,000 | -99.9% | 539 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $20,595,000 | -4.0% | 539 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $21,463,000 | +11.6% | 539 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $19,237,000 | +96085.0% | 539 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $20,000 | -99.9% | 539 | 0.0% | 0.00% | -66.7% |
Q3 2020 | $20,288,000 | -7.8% | 539 | -19.4% | 0.00% | 0.0% |
Q2 2020 | $22,007,000 | +7.8% | 669 | +24.1% | 0.00% | -25.0% |
Q1 2020 | $20,423,000 | -74.6% | 539 | -68.5% | 0.00% | -63.6% |
Q4 2019 | $80,494,000 | +110165.8% | 1,713 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $73,000 | -99.9% | 1,713 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $68,554,000 | -4.2% | 1,713 | 0.0% | 0.01% | -8.3% |
Q1 2019 | $71,586,000 | +357830.0% | 1,713 | +217.8% | 0.01% | +200.0% |
Q4 2018 | $20,000 | -55.6% | 539 | -52.7% | 0.00% | -55.6% |
Q3 2018 | $45,000 | – | 1,139 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |